Patient-physician interactions in hereditary angioedema-Key learnings from the coronavirus disease 2019 pandemic.

"CONFLICT OF INTEREST STATEMENT Medical writing assistance was provided by Meridian HealthComms Ltd., funded by CSL Behring. Marcus Maurer is or recently was a speaker and/or advisor for and/or has received research funding from Alnylam, BioCryst, Centogene, CSL Behring, Dyax, Kalvista, Pharming, Pharvaris, and Shire/Takeda. Thomas Buttgereit is or recently was a speaker and/or advisor and/or consultant for BioCryst, CSL Behring, Takeda, Pharming and KalVista. Markus Magerl is or recently was a speaker and/or advisor for BioCryst, CSL Behring, Octapharma, Pharvaris, Takeda and KalVista. Kathrin Schön is or recently was a speaker for BioCryst, CSL Behring and Takeda. Zsusanna Balla is or recently was a speaker and/or has received research funding from CSL Behring, Pharvaris and Takeda. Henriette Farkas is or recently was a speaker and/or advisor for and/or has received research funding from Astria, BioCryst, CSL Behring, Shire/Takeda, Pharming, KalVista, Pharvaris and ONO Pharmaceutical."

"Medical writing assistance was funded by CSL Behring. Medical writing assistance was provided by Katie Dogan of Meridian HealthComms Ltd, Plumley, UK. Open Access funding enabled and organized by Projekt DEAL."